Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.48 CNY | +2.35% | +6.62% | -9.13% |
Business Summary
Number of employees: 424
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drugs
100.0
%
| 0 | nan % | 91 | 100.0 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | nan % | 91 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Qing Bei Zeng
CTO | Chief Tech/Sci/R&D Officer | 62 | 17-11-30 |
Zhen Fan Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 17-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Xin Zhang
BRD | Director/Board Member | 52 | 20-09-07 |
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Director/Board Member | 51 | 17-09-30 | |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Bin Jiang
BRD | Director/Board Member | 60 | 20-09-07 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 415,653,120 | 76,783,646 ( 18.47 %) | 0 | 18.47 % |
Company contact information
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Building 4 199, 245 Liangjing Road
201203, Shanghai
+
http://www.dizalpharma.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.13% | 2.5B | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 688192 Stock
- Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.